CaldwellDRVerinPHartwich-YoungRMeyerSMDrakeMM. Efficacy and safety of lodoxamide 0.1 % vs. cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol1992; 113: 632–7.
2.
Diseases of the conjunctiva. In: Sanford-SmithJ, eds. Eye diseases in hot climates. 2nd ed. London: Wright, 1990: 70–2.
3.
VaughanDAshburyTRiordan-EvaP, eds. General ophthalmology. Norwalk, CT: Appleton and Lange, 1992: 111–2.
4.
FahyGTEastyDLCollumLMTBenedict-SmithAHilleryMParsonsDG. Randomized double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicenter study. Eur J Ophthalmol1992; 2: 144–9.
5.
SantosCIHuangAJAbelsonMBFosterCSFriedlaenderMMcCulleyJP. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol1994; 117: 488–97.
6.
RenfroLSnowJS. Ocular effects of topical and systemic steroids. Dermatol Clin1992; 10: 505–12.
7.
HollandEJOlsenTWKetchamJMFlorineCKrachmerJHPurcellJJ. Topical cyclosporine A in the treatment of anterior segment inflammatory disease. Cornea1993; 12: 413–9.
8.
AbramowitzM, ed. Ophthalmic levocabastine for allergic conjunctivitis. Med Lett1994; 36: 35–7.
9.
AbelsonMBSloanJ. Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapy. J Fla Med Assoc1994; 81: 261–3.
10.
TinkelmanDGRuppGKaufmanHPugelyJSchultzN. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared to placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol1993: 38 (suppl): 133–40.
11.
BallasZBlumenthalMTinkelmanDGKrizRRuppG. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol1993; 38 (suppl): 141–8.
12.
NewellFW. Ophthalmology principles and concepts. 5th ed. St. Louis: CV Mosby, 1982: 193.
13.
KaanGOzdenO. Therapeutic use of topical cyclosporine. Ann Ophthalmol1993; 25: 182–6.
14.
BleikJHTabbaraKF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology1991; 98: 1679–84.
15.
SecchiAGTognonMSLeonardiA. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol1990; 110: 641–5.
16.
GarretHM, ed. Drug topics redbook update. Medical Economics, 1995.
17.
JohnsonHGVan HoutCAWrightJB. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. Int Arch Allergy Appl Immunol1978; 56: 416–23.
JohnsonHGGriffinRLWrightJB. The effect of lodoxamide ethyl [diethyl N, N'-(2-chloro-5-cyano-m-phenylene) dioxamate] on in vivo anaphylactic reactions. Agents Actions1979; 9: 235–8.
